financetom
Market
financetom
/
Market
/
Perpetua Resources Up 6% After Securing US$255 Million Financing From Agnico Eagle, JPMorganChase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Perpetua Resources Up 6% After Securing US$255 Million Financing From Agnico Eagle, JPMorganChase
Oct 27, 2025 5:23 AM

08:05 AM EDT, 10/27/2025 (MT Newswires) -- Perpetua Resources ( PPTA ) traded 6.4% up at last look Monday in Nasdaq pre-market trading as it entered agreements to raise US$255 million in equity investments from Agnico Eagle Mines ( AEM ) and JPMorganChase.

Perpetua plans to use the proceeds to advance development of the Stibnite gold project in Idaho, where the company recently broke ground, as well as for general corporate purposes.

"The investments from Agnico Eagle and JPMorganChase are a vote of confidence in the Stibnite Gold Project and America's critical mineral strategy," Perpetua president and chief executive officer Jon Cherry said. "Investments from two leading, world-class institutions strengthens our capital position, reduces financing risk, and accelerates the development of one of the nation's most strategic resource projects."

Under the terms, Agnico Eagle agreed to invest $180 million in common shares, resulting in a 6.5% equity stake in Perpetua on a non-diluted basis.

Agnico Eagle will also receive warrants to purchase up to 2,861,229 common shares priced at a 35% premium for one year, 50% for two years and 65% for three years.

Meanwhile, JPMorganChase agreed to invest $75 million in common shares for a 2.7% equity stake in Perpetua. JPMorganChase will also receive warrants to purchase up to 1,192,179 common shares priced at a 35% premium for one year, 50% for two years and 65% for three years.

The offering was priced at $23.30 per common share, which was Perpetua's closing share price on Nasdaq last Friday.

The private placement is expected to close by Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Middle East Conflict Weighs on Investor Sentiment, Driving Premarket Losses for US Equity Futures
Middle East Conflict Weighs on Investor Sentiment, Driving Premarket Losses for US Equity Futures
Mar 26, 2026
08:28 AM EDT, 03/26/2026 (MT Newswires) -- US equity futures were lower pre-bell Thursday as traders monitored the latest developments in the Middle East. Dow Jones Industrial Average futures were 0.9% lower, S&P 500 futures were down 1%, and Nasdaq futures were 1.1% lower. On Wednesday, Iran rejected Washington's proposal to pause the war in the Middle East, with Tehran's...
Sector Update: Tech
Sector Update: Tech
Mar 26, 2026
08:52 AM EDT, 03/26/2026 (MT Newswires) -- Technology stocks were falling premarket Thursday, with the State Street Technology Select Sector SPDR Fund (XLK) down 1.4% and the State Street SPDR S&P Semiconductor ETF (XSD) 3.1% lower. Super Micro Computer ( SMCI ) shareholders sued the company Wednesday, accusing it of committing securities fraud by concealing its dependence on sales to...
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Ongoing Middle East Tensions
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Ongoing Middle East Tensions
Mar 26, 2026
08:56 AM EDT, 03/26/2026 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was down 0.8% and the actively traded Invesco QQQ Trust (QQQ) retreated 1% in Thursday's premarket activity amid ongoing tensions in the Middle East. US stock futures were also lower, with S&P 500 Index futures down 0.8%, Dow Jones Industrial...
Sector Update: Health Care
Sector Update: Health Care
Mar 26, 2026
08:56 AM EDT, 03/26/2026 (MT Newswires) -- Health care stocks were leaning lower premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) declining by 0.7%. Ascentage Pharma Group ( AAPG ) shares were down more than 2% after the company reported a wider 2025 loss as revenue declined...
Copyright 2023-2026 - www.financetom.com All Rights Reserved